Obesity Clinical Trial
Official title:
Investigating Fitness Interventions in the Elderly (INFINITE)
Aging is associated with declines in aerobic capacity, exercise tolerance, and functional endurance that lead to physical disability and loss of independence. Furthermore, the existing high prevalence of obesity in the elderly is greatly exacerbating these aging-related declines in function. To date, regular exercise is the only known therapy to consistently improve aerobic function, and perhaps delay the onset of disability. Although aerobic exercise training does benefit both aerobic capacity and endurance even in obese persons, some data show that the maximal efficacy of exercise for improving aerobic function is blunted by obesity. In addition, our preliminary data show a potential dose-response benefit of concomitant fat loss on exercise-induced improvements in aerobic function. Thus, combining an exercise intervention with caloric restriction resulting in fat loss may be more efficacious for improving aerobic function than exercise alone in obese elderly, a population at high risk for disability. The purpose of this study is to determine whether the amount of fat loss (achieved through controlled underfeeding) affects the magnitude of improvement in aerobic function (maximal aerobic capacity and endurance) in response to a standardized exercise training stimulus that follows current recommendations for older persons.
Design Overview:
Phase 1 involves recruitment and screening followed by baseline research testing (Phase 2).
Next, subjects will be randomly assigned to one of three 5-month treatments (Phase 3):
exercise and high-caloric restriction diet, exercise and low-caloric restriction diet, or
exercise only. Subjects will complete follow-up testing after their 5 month intervention.
Interventions:
Dietary interventions: All participants will be randomly assigned to an exercise intervention
with either no dietary intervention (EX Only), or 1 of 2 hypocaloric controlled diets: 1)
-250 kcal/day deficit for low fat loss (EX+LOW CR) or 2) -600 kcal/day deficit for high fat
loss (EX+HIGH CR) for 20 weeks.
All meals are prepared individually after participants choose from a hypocaloric menu
designed by the RD to provide a balanced, healthy diet. The calorie level assigned for each
person will provide him/her with an absolute daily caloric deficit consistent with their
group assignment (-600 or -250 kcals/day). Individual calorie levels will be prescribed to
provide calorie levels to the nearest 50 kcals (e.g., 1100 kcal, 1150 kcal, 1200 kcal, etc.).
They are educated by the GCRC RDs and provided menus to guide their food purchasing and
preparation of daily breakfast meals that are consistent with the prescribed calorie level.
They are asked to consume only the food that is given to them or that is approved from the
breakfast menu. All participants will pick up their food 3 times/wk during the intervention,
and are asked to keep a log of everything they eat or drink.
Exercise intervention: The exercise will take place in an exercise facility at the Geriatric
Research Center on the campus of the Wake Forest University/Baptist Medical Center. Two study
personnel, including at least one trained technician, will supervise all exercise sessions.
Emergency equipment will be kept on site during exercise sessions. Blood pressure and heart
rate (HR) will be measured before each exercise session and subjects will warm-up by walking
for 3-5 min at a slow pace and will then walk at an intensity of 65-70% of heart rate reserve
(HRR, assessed during the VO2max test). The duration of walking exercise will progress from
15-20 mins at 50% HRR the 1st week to 30 mins at 65-70% HRR by the end of the 6th week and
thereafter. Each walking session will end with a 3-5 min cool-down followed by 5 min of large
muscle flexibility exercise.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |